
Insider Sale Alert: Avidity Biosciences Inc [RNA] – Is it Time to sell?
Avidity Biosciences Inc’s filing revealed that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $0.16 million
Avidity Biosciences Inc’s filing revealed that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $0.16 million
Avidity Biosciences Inc’s recently made public that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $0.16
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Avidity Biosciences Inc’s filing revealed that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $0.16 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Avidity Biosciences Inc’s filing revealed that its Chief Medical Officer Hughes Steven George unloaded Company’s shares for reported $0.3 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Avidity Biosciences Inc’s filing revealed that its Chief Medical Officer Hughes Steven George unloaded Company’s shares for reported $0.3 million
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.